PST-611

· Eyevensys

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PST-611, covering 2025-06-17 to 2025-06-17. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Tolerability Clinical Trial of PST-611 in Dry Age-related Macular Degeneration [Phase 1]